-
Patients with burn injuries are at high risk for major infections, given their impaired humoral and cellular immunity. Moreover, this patient population displays numerous physiologic alterations affecting organ function and drug metabolism.
-
-
In this issue: Some women with DVT may stop warfarin after six months; Vytorin and cancer; preventing recurrent stroke; and FDA news.
-
Although reactivation of CMV has significant adverse consequences for immunocompromised patients, such as those receiving organ transplants, the effect of CMV reactivation in critically ill immunocompetent patients is unclear.
-
Investigators at a number of university-affiliated HIV clinics around the United States conducted the Living Positively Survey to explore the experiences and attitudes of HIV+ woman toward health care, treatment, pregnancy, and family issues.
-
Resistance to oseltamivir (tamifluR) has increased in Influenza A isolates around the world at an alarming rate. Levels of resistance now range from 13% in Chile to 100% (10 of 10 isolates) in Australia.
-
Although Enzyme-Immunoassay (EIA) tests have replaced cytotoxin assays for diagnosis of Clostridium difficile-associated diarrhea (CDAD) in most US laboratories, the changing epidemiology of this disease suggests that an adjustment in diagnostic testing algorithms is needed.
-
A retrospective review of 211 inpatients admitted to the US Navy hospital ship USNS Comfort in early 2003 revealed 57 patients with A. baumannii infection.
-
Central nervous system infection due to free-living amebae generally manifests as either acute meningitis or focal encephalitis.
-
The inevitability of progression of bacterial resistance to antibiotics used in the clinic and other settings dictates the need for approaches that go beyond antimicrobial stewardship and the development of new antibiotics.
